Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Maguire

Showing results (291-300 of 322) with videos related to

Pageof 33
Sort By:
American Journal of Ophthalmology|February 10, 2023
Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 YearsJacque L Duncan, Peiyao Cheng, Maureen G Maguire, et al.
Experimental Eye Research|May 17, 2002
Macular pigment and lutein supplementation in choroideremiaJacque L Duncan, Tomas S Aleman, Leigh M Gardner, et al.
Cornea|January 22, 2019
Comparison of Donor Cornea Endothelial Cell Density Determined by Eye Banks and by a Central Reading Center in the Cornea Preservation Time StudyBeth Ann Benetz, Christopher G Stoeger, Sanjay V Patel, et al.
Ophthalmology|January 13, 2006
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosisJennifer B Fisher, Dina A Jacobs, Clyde E Markowitz, et al.
American Journal of Medical Genetics. Part A|July 31, 2021
Auditory and olfactory findings in patients with USH2A-related retinal degeneration-Findings at baseline from the rate of progression in USH2A-related retinal degeneration natural history study (RUSH2A)Alessandro Iannaccone, Carmen C Brewer, Peiyao Cheng, et al.
Archives of Neurology|November 11, 2009
Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosisBryn M Burkholder, Benjamin Osborne, Michael J Loguidice, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 10, 2014
Retinopathy and progression of CKD: The CRIC studyJuan E Grunwald, Maxwell Pistilli, Gui-Shuang Ying, et al.
The British Journal of Ophthalmology|June 7, 2020
Progression of retinopathy and incidence of cardiovascular disease: findings from the Chronic Renal Insufficiency Cohort StudyJuan E Grunwald, Maxwell Pistilli, Gui-Shuang Ying, et al.
The New England Journal of Medicine|July 14, 2022
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular EdemaChirag D Jhaveri, Adam R Glassman, Frederick L Ferris, et al.
Cell Metabolism|May 15, 2018
Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine ToxicityJoshua D Ochocki, Sanika Khare, Markus Hess, et al.
Pageof 33

Showing results (291-300 of 322) with videos related to

Sort By:
Pageof 33
American Journal of Ophthalmology|February 10, 2023
Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 YearsJacque L Duncan, Peiyao Cheng, Maureen G Maguire, et al.
Experimental Eye Research|May 17, 2002
Macular pigment and lutein supplementation in choroideremiaJacque L Duncan, Tomas S Aleman, Leigh M Gardner, et al.
Cornea|January 22, 2019
Comparison of Donor Cornea Endothelial Cell Density Determined by Eye Banks and by a Central Reading Center in the Cornea Preservation Time StudyBeth Ann Benetz, Christopher G Stoeger, Sanjay V Patel, et al.
Ophthalmology|January 13, 2006
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosisJennifer B Fisher, Dina A Jacobs, Clyde E Markowitz, et al.
American Journal of Medical Genetics. Part A|July 31, 2021
Auditory and olfactory findings in patients with USH2A-related retinal degeneration-Findings at baseline from the rate of progression in USH2A-related retinal degeneration natural history study (RUSH2A)Alessandro Iannaccone, Carmen C Brewer, Peiyao Cheng, et al.
Archives of Neurology|November 11, 2009
Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosisBryn M Burkholder, Benjamin Osborne, Michael J Loguidice, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 10, 2014
Retinopathy and progression of CKD: The CRIC studyJuan E Grunwald, Maxwell Pistilli, Gui-Shuang Ying, et al.
The British Journal of Ophthalmology|June 7, 2020
Progression of retinopathy and incidence of cardiovascular disease: findings from the Chronic Renal Insufficiency Cohort StudyJuan E Grunwald, Maxwell Pistilli, Gui-Shuang Ying, et al.
The New England Journal of Medicine|July 14, 2022
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular EdemaChirag D Jhaveri, Adam R Glassman, Frederick L Ferris, et al.
Cell Metabolism|May 15, 2018
Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine ToxicityJoshua D Ochocki, Sanika Khare, Markus Hess, et al.
Pageof 33